These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35510275)

  • 1. A New and Easier Approach to Preserflo MicroShunt Implantation.
    Fea AM; Ghilardi A; Bovone D; Reibaldi M; Rossi A; Craven ER
    Clin Ophthalmol; 2022; 16():1281-1288. PubMed ID: 35510275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ab externo implantation of the MicroShunt, a poly (styrene-
    Sadruddin O; Pinchuk L; Angeles R; Palmberg P
    Eye Vis (Lond); 2019; 6():36. PubMed ID: 31807606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma.
    Ahmed IIK; Sadruddin O; Panarelli JF
    Eye Vis (Lond); 2023 Mar; 10(1):10. PubMed ID: 36859515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XEN
    Scheres LMJ; Kujovic-Aleksov S; Ramdas WD; de Crom RMPC; Roelofs LCG; Berendschot TTJM; Webers CAB; Beckers HJM
    Acta Ophthalmol; 2021 May; 99(3):e433-e440. PubMed ID: 32909682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PreserFlo MicroShunt® exposure: a case series.
    Bunod R; Robin M; Buffault J; Keilani C; Labbé A; Baudouin C
    BMC Ophthalmol; 2021 Jul; 21(1):273. PubMed ID: 34246229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Novel Αb Εxterno MicroShunt for the Treatment of Glaucoma.
    Burgos-Blasco B; García-Feijóo J; Perucho-Gonzalez L; Güemes-Villahoz N; Morales-Fernandez L; Mendez-Hernández CD; Martinez de la Casa JM; Konstas AG
    Adv Ther; 2022 Sep; 39(9):3916-3932. PubMed ID: 35797002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell loss 5 years after Preserflo MicroShunt implantation: About two cases.
    Chamard C; Hammoud S; Bluwol E; Lachkar Y
    Am J Ophthalmol Case Rep; 2022 Mar; 25():101238. PubMed ID: 34977424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study.
    Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L
    Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review.
    Saeed E; Gołaszewska K; Dmuchowska DA; Zalewska R; Konopińska J
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Pressure Characteristics of the PRESERFLO MicroShunt in In Vitro Studies and Effects of Sclera on Device Performance.
    Masdipa A; Kaidzu S; Tanito M
    J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PreserFlo
    Gambini G; Carlà MM; Giannuzzi F; Caporossi T; De Vico U; Savastano A; Baldascino A; Rizzo C; Kilian R; Caporossi A; Rizzo S
    Vision (Basel); 2022 Feb; 6(1):. PubMed ID: 35225971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Surgical management of vitreous obstruction following PreserFlo ® MicroShunt implantation.
    Tondini G; Staurenghi G; Bochicchio S; Dipinto A; Cereda MG; Stefano A
    Am J Ophthalmol Case Rep; 2023 Dec; 32():101967. PubMed ID: 38077778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRESERFLO™ Microshunt: 1-Year Results of a 25-Gauge vs. 27-Gauge Needle Tract.
    Steiner S; Resch H; Kiss B; Vass C
    J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610744
    [No Abstract]   [Full Text] [Related]  

  • 14. A Case of Delayed-onset Hemorrhagic Choroidal Detachment After PreserFlo Microshunt Implantation in a Glaucoma Patient Under Anticoagulant Therapy.
    Micheletti E; Riva I; Bruttini C; Quaranta L
    J Glaucoma; 2020 Aug; 29(8):e87-e90. PubMed ID: 32568812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of malignant glaucoma following insertion of Preserflo™ MicroShunt.
    Gizzi C; Costa G; Servadei R; Abed E; Ning B; Sharma A; Barton K
    Eur J Ophthalmol; 2022 Jul; 32(4):NP115-NP119. PubMed ID: 33736487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes to Corneal Topography and Biometrics After PRESERFLO Microshunt Surgery for Glaucoma.
    Ibarz Barberá M; Morales-Fernandez L; Gómez de Liaño R; Tañá Rivero P; Teus MA
    J Glaucoma; 2021 Oct; 30(10):921-931. PubMed ID: 34255755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mini Drainage Devices for Anterior and Intermediate Filtration.
    Nardi M; Posarelli C; Nasini F; Figus M
    Dev Ophthalmol; 2017; 59():90-99. PubMed ID: 28442690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ab-Externo Implantation of XEN Gel Stent for Refractory Steroid-Induced Glaucoma After Lamellar Keratoplasty.
    Tan SY; Md Din N; Mohd Khialdin S; Wan Abdul Halim WH; Tang SF
    Cureus; 2021 Feb; 13(2):e13320. PubMed ID: 33738163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation.
    Vastardis I; Fili S; Perdikakis G; Kontopoulou K; Balidis M; Gatzioufas Z; Kohlhaas M
    Eye Vis (Lond); 2021 Sep; 8(1):33. PubMed ID: 34479641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of PreserFlo
    Quaranta L; Micheletti E; Carassa R; Bruttini C; Fausto R; Katsanos A; Riva I
    Adv Ther; 2021 Aug; 38(8):4403-4412. PubMed ID: 34251652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.